Magnesium Zirconate Titanate Thin Films Used as an NO(2) Sensing Layer for Gas Sensor Applications Developed Using a Sol–Gel Method

por Huang, Pei-Shan, Lee, Ke-Jing, Wang, Yeong-Her
Publicado 2021

WNT Signaling as a Therapeutic Target for Glioblastoma

por Latour, Michael, Her, Nam-Gu, Kesari, Santosh, Nurmemmedov, Elmar
Publicado 2021

PangenomeNet: a pan-genome-based network reveals functional modules on antimicrobial resistome for Escherichia coli strains

por Her, Hsuan-Lin, Lin, Po-Ting, Wu, Yu-Wei
Publicado 2021

Identification of a transcriptional signature found in multiple models of ASD and related disorders

por Thudium, Samuel, Palozola, Katherine, L'Her, Éloïse, Korb, Erica
Publicado 2022

Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial

por Stebbing, Justin, Baranau, Yauheni, Baryash, Valery, Moiseyenko, Vladimir, Boliukh, Dmytro, Antone, Nicoleta, Manikhas, Alexey, Chornobai, Anatolii, Park, Taehong, Baek, Eric Hyungseok, Lee, Jaeyong, Choi, Jiin, Kim, Nahyun, Ahn, Keumyoung, Lee, Sang Joon, Kim, Sunghyun
Publicado 2023

Pathologic Complete Response Achieved in Early-Stage HER2-Positive Breast Cancer After Neoadjuvant Therapy With Trastuzumab and Chemotherapy vs....

por Fazal, Faizan, Bashir, Muhammad Nauman, Adil, Maham Leeza, Tanveer, Usama, Ahmed, Mansoor, Chaudhry, Taha Zahid, Ijaz, Ali Ahmad, Haider, Muhammad
Publicado 2023

Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings

por Hashmi, Atif A, Bukhari, Ummara, Najam, Javeria, Dowlah, Tanim, Ali, Abrahim H, Diwan, Muhammad Asad, Anjali, FNU, Sham, Sunder, Zia, Shamail, Irfan, Muhammad
Publicado 2023

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

por Ünal, Çağlar, Özmen, Tolga, Ordu, Çetin, Pilanci, Kezban Nur, İlgün, Ahmet Serkan, Gökmen, Erhan, Almuradova, Elvina, Özdoğan, Mustafa, Güler, Nilüfer, Uras, Cihan, Kara, Halil, Demircan, Orhan, Işık, Selver, Alço, Gül, Saip, Pınar, Aydın, Esra, Duymaz, Tomris, Çelebi, Filiz, Yararbaş, Kanay, Soybir, Gursel, Ozmen, Vahit
Publicado 2023

Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S....

por Mistry, Rohit, May, Jessica R., Suri, Gaurav, Young, Kate, Brixner, Diana, Oderda, Gary, Biskupiak, Joseph, Tang, Derek, Bhattacharyya, Subrata, Mishra, Dinesh, Bhattacharyya, Devarshi, Dalal, Anand A.
Publicado 2018

Combination therapy with antibody‑drug conjugate RC48 (disitamab vedotin) and zimberelimab (PD‑1 inhibitor) successfully controlled recurrent HER2‑positive breast cancer resistant to trastuzumab emtansine: A case report

por Fan, Shanmin, He, Lianxiang, Sang, Die
Publicado 2023

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

por von Minckwitz, Gunter, Sinn, Hans-Peter, Raab, Günter, Loibl, Sibylle, Blohmer, Jens-Uwe, Eidtmann, Holger, Hilfrich, Jörn, Merkle, Elisabeth, Jackisch, Christian, Costa, Serban D, Caputo, Angelika, Kaufmann, Manfred
Publicado 2008

Assessing HER2 amplification by IHC, FISH, and real-time polymerase chain reaction analysis (real-time PCR) following LCM in formalin-fixed paraffin embedded tissue from 40 women with ovarian cancer

por Hillig, Thore, Thode, Jørgen, Breinholt, Marie F, Franzmann, Maria-Benedicte, Pedersen, Carsten, Lund, Flemming, Mygind, Henrik, Sölétormos, György, Rudnicki, Martin
Publicado 2012

A recombinant HER2/neu expressing listeria monocytogenes (Lm-LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma - a Phase I clinical trial

por Gnanandarajah, Josephine S, Ndikuyeze, Georges Habineza, Engiles, Julie B, Wallecha, Anu, Mason, Nicola
Publicado 2014

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy

por Muraro, E, Comaro, E, Talamini, R, Turchet, E, Miolo, G, Scalone, S, Militello, L, Lombardi, D, Spazzapan, S, Perin, T, Massarut, S, Crivellari, D, Dolcetti, Riccardo, Martorelli, D
Publicado 2015

Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice

por N.Tinianow, Jeff, Pandya, Darpan N., Pailloux, Sylvie L., Ogasawara, Annie, Vanderbilt, Alexander N., Gill, Herman S., Williams, Simon-P., Wadas, Thaddeus J., Magda, Darren, Marik, Jan
Publicado 2016

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18

por Finn, Richard S., Crown, John P., Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M., Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T., Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J.
Publicado 2016